- No posts yet.
- NeoGenomics Makes Oncology Test Ordering Available Through Epic Aura EHR Integration ir.neogenomics.com | 47d ago
- NeoGenomics Launches RaDaR ST for MRD Detection Across Multiple Solid Tumors neogenomics.com | 14d ago
- NeoGenomics launches RaDaR ST ctDNA assay for molecular residual disease detection across solid tumor types ir.neogenomics.com | 104d ago
- NeoGenomics Launches RaDaR ST MRD Test for HR+/HER2- Breast Cancer neogenomics.com | 14d ago
- NeoGenomics to Present Eight Abstracts at ASCO 2026 Meeting ir.neogenomics.com | 14d ago
- NeoGenomics launches PanTracer LBx liquid biopsy CGP test for advanced solid tumors ir.neogenomics.com | 314d ago
- NeoGenomics launches PanTracer Tissue and PanTracer Tissue HRD for advanced cancer diagnostics ir.neogenomics.com | 344d ago
- NeoGenomics Launches RaDaR ST for HPV-Negative Head and Neck Cancer MRD Detection neogenomics.com | 69d ago
- NeoGenomics Launches RaDaR ST for Molecular Residual Disease Detection in Solid Tumors ir.neogenomics.com | 104d ago
- NeoGenomics Launches PanTracer LBx, a Liquid Biopsy Comprehensive Genomic Profiling Test ir.neogenomics.com | 314d ago
- NeoGenomics makes oncology test portfolio available through Epic Aura ir.neogenomics.com | 47d ago
- NeoGenomics to Present Eight Abstracts at ASCO 2026 Covering MRD, NGS, and Real-World Evidence ir.neogenomics.com | 14d ago
- NeoGenomics Launches PanTracer Tissue and PanTracer Tissue HRD Assays ir.neogenomics.com | 344d ago
Showing page 1 of 1
(13 total results)
← Prev
Next →